(Q36026045)

11 August 2017

Predicting prostate cancer many years before diagnosis: how and why? (English)

1 reference

11 August 2017

1 reference

Hans Lilja

2

0 references

Andrew Vickers

object named as

Andrew J Vickers

series ordinal

1

0 references

publication date

20 November 2011

1 reference

11 August 2017

World Journal of Urology

1 reference

11 August 2017

30

1 reference

11 August 2017

2

1 reference

11 August 2017

131-135

1 reference

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Estimation of absolute risk for prostate cancer using genetic markers and family history

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Screening and prostate-cancer mortality in a randomized European study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373007

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0795-8

Balancing the harms and benefits of early detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0795-8

Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0795-8

Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0795-8

Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0795-8

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22101902

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22101902

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cumulative association of five genetic variants with prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22101902

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00345-011-0795-8

1 reference

11 August 2017

1 reference

PMC publication ID

3373007

11 August 2017

PubMed publication ID

22101902

1 reference

PMC publication ID

3373007